CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » NURSES

ONCOLOGY Nurse Edition. Vol. 24 No. 2
Pages: 1  2  3  
Next
The Lea/Calzone Article Reviewed 

Genetics and Genomics: A New Frontier in Oncology

By Suzanne M. Mahon, RN, DNSc, AOCN, APNG
Professor, Department of Internal Medicine
Professor, Adult Nursing, School of Nursing
Saint Louis University
St. Louis, Missouri | February 16, 2010

Lea and Calzone have provided an outstanding overview of genetics and genomic research applicable to the subspecialty of oncology nursing. The ever-emerging discoveries in this discipline mandate that nurses understand the key concepts of genetics and genomics and their everyday application to comprehensive care of the oncology patient and family throughout all phases of the trajectory of cancer care.

All nurses need to be familiar with the document Essentials of Genetic and Genomic Nursing.[1] This resource emphasizes that all nurses should understand the role of both genetics and genomics in healthcare. Genetics is the study of individual genes and the ways in which their expression or dysfunction impacts the development of relatively rare single-gene disorders. Many mistakenly believe that genetics and genomics are interchangeable and that genetics explains how all disease, including cancer, develops.

Genomics is an exploding area of interest in oncology care and includes the study of all genes in the human genome together, including their interactions with each other and the environment, as well as the influence of psychosocial and cultural factors on the development of disease, such as cancer. Lea and Calzone provide numerous relevant clinical examples of applied genomics, describing how the science of genomics relates to personalized healthcare.

Nurses need to be able to explain basic concepts of genetics and genomics to patients and families. One area that often requires clarification involves the transmission of hereditary risk. Gene mutations can be inherited, spontaneous, or acquired. Inherited gene mutations, called germline mutations, are present in all body cells. They are passed on from parent to child in reproductive cells (the egg and sperm), and are present in all of the cells in that child's body when the body cells reproduce. A spontaneous mutation can occur in individual eggs or sperm at conception. A person who has the new, spontaneous mutation is at risk of passing the mutated gene to his or her children.

Acquired mutations, also called somatic mutations, occur in body cells other than egg or sperm. They involve changes in DNA that take place after conception, during a person's lifetime. Acquired mutations result from cumulative changes in body cells other than egg or sperm, called somatic cells. Somatic gene mutations are passed on when the cells they contain reproduce. Frequently patients will state that they underwent genetic testing, thinking that such testing implies hereditary risk, when in reality they may have had testing of their tumor, such as HER2 (human epidermal growth factor receptor 2) testing to direct treatment decisions. Nurses need to be able to explain basic genetic concepts in terms that can be understood by patients and families.

It is important for oncology nurses to recognize when a person may potentially have a hereditary (germline mutation) risk for developing cancer and when it is appropriate to refer that individual and family for further genetic risk assessment, evaluation, and possibly genetic testing. This relatively small subset of individuals and families should be referred to a credentialed genetics professional for evaluation.[2] Clearly, identification of a germline mutation and family members at significantly high risk for developing cancer can result in targeted and potentially effective prevention and early detection strategies, and this traditional application of genetics is essential to good oncology nursing.

Pages: 1  2  3  
Next
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

  • Oldest First
  • Newest First

by Alvin Basil | February 13, 2012 1:27 AM EST

I'm really looking forward to your future posts, it's always so interesting.

dermal filler






 
RELATED CONTENT

Implementing a Comprehensive Infection-Prevention Plan
May 6, 2013
ONS: Infection Risk, Prevention, and Management
April 29, 2013
ONS: Nurse-Physician PACT Yields Sharp Decrease in Codes
April 29, 2013
ONS: Safe Handling of Chemotherapy
April 29, 2013
ONS: Health IT as a Tool for Improved, Patient-Centric Care
April 26, 2013
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Skin Lesions
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Colorectal Lesions
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Conflicts of Interest in Medicine: What About Ties to Payers?
Click here to subscribe to our newsletter



CancerNetwork on Facebook
 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Oncology Nursing
Evidence on Oncology Nursing
Guidelines on Oncology Nursing
Patient Education on Oncology Nursing
Clinical Trials on Oncology Nursing
Practical Articles on Oncology Nursing
Research and Reviews on Oncology Nursing
All "Oncology Nursing" results

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy